
    
      The study will be an un-blinded, Phase 2, randomized, 1:1, prospective trial comparing
      methylene blue versus terlipressin in treatment of preterm neonate with catecholamines
      resistant septic shock the outcome as regard elevation of mean arterial blood pressure will
      be measured within 72 hours
    
  